FULCRUM THERAPEUTICS INC. - COMMON STOCK
3,8200
04-октября-24 14:59:57
15 мин. задержка
Акции
+0,1550
+4,23%
Сегодняшний диапазон
3,6850 - 3,8400
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 сен 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
12 сен 2024 05:55:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate in Upcoming September Conferences
27 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 авг 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
19 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 авг 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
31 июл 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
24 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Present at the 31st Annual FSHD Society International Research Congress
12 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate in the Goldman Sachs’ 45th Annual Global Healthcare Conference
06 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
13 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
13 май 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate in Upcoming May Conferences
09 май 2024 07:00:01 Источник Nasdaq GlobeNewswire
-
08 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
06 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
28 мар 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22 мар 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
18 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 мар 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
05 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >